Mrs. Tosilah Wati underwent brain tumor surgery in October 2012. The pathology results showed a malignant cancer type, astrocytoma grade 1. Six months after the surgery, followed by 30 rounds of radiation, her tumor mass reappeared in two locations at the previous surgery sites. An MRI result one year after the surgery showed the tumor mass had spread to more than half of the right hemisphere of the brain, pushing the midline of the brain and pressing into the left side. It seemed the cancer grade had increased. Unable to be controlled by surgery and radiation, Mrs. Tosilah tried the ECCT alternative therapy starting in early December 2013. Her condition gradually improved as the mass in her brain started to shrink. After two years of using ECCT, the mass significantly reduced, and the spread and widespread edema surrounding the initial mass had relatively disappeared. However, the tumor mass only disappeared after five years of use, which was relatively slow compared to the typical response of astrocytoma to ECCT. The response characteristics were consistent with those of low-grade glioma. Ten years after using ECCT, or twelve years since her initial brain cancer diagnosis, Mrs. Tosilah is healthy and normal, free from cancer..
Image: The MRI results of Mrs. Tosilah Wati’s brain before ECCT therapy show the mass growing rapidly despite surgery and radiation (top-right); the mass starts shrinking after ECCT use and becomes CLEAR after five years (Top 3rd from right); The electrical activity of the tumor mass during therapy monitored with ECVT; a photo of Mrs. Tosilah Wati after 5 years and 10 years of using ECCT (bottom).
Mrs. Tosilah Wati first underwent brain tumor surgery in October 2012. The pathology results showed a malignant type, astrocytoma grade 1. After the surgery and pathology results, she underwent 30 rounds of radiation. The skull had not yet been reattached when, approximately six months after the surgery and radiation, an MRI showed the mass had reappeared in two places around the initial mass. The new tumor sizes were 2 cm and 4 cm, larger than the original mass before surgery. The grade seemed to have increased as well.
As the tumor reappeared, Mrs. Tosilah experienced worsening symptoms daily, with increasingly frequent seizures. An MRI result one year after surgery showed the recurring mass at the previous surgery site had expanded to more than half of the right hemisphere of the brain, pushing into the left side, crossing the brain’s midline.
The cancer’s progression could not be halted despite surgery and radiation, so Mrs. Tosilah eventually tried ECCT in early December 2013. A year after surgery and before using ECCT, Mrs. Tosilah could not hold anything with her left hand. To stand or walk, she had to use a support with her right hand. She experienced seizures every 1-2 weeks. After using ECCT, she still had a seizure on the first day, but none afterward. Her condition gradually improved with continued use of the device.
Two years after using ECCT, the mass had shrunk significantly, and the widespread spread around the initial mass had relatively disappeared. The tumor mass only disappeared after five years of use, which was relatively slow compared to the typical response of astrocytoma to ECCT, consistent with the characteristics of low-grade glioma.
In 2024, Mrs. Tosilah successfully reached 10 years after using ECCT, or 12 years since her first brain cancer diagnosis. She is healthy and normal, free from cancer. Best wishes for continued health to Mrs. Tosilah.
